The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to Medical Statistics.
(1931) · Journal of the American Medical Association · doi:10.1001/jama.1931.02730150055037 · Cited by 2,084
Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases
Ducatman, B. S., Scheithauer, B. W., Piepgras, D. G., Reiman, H. M., & Ilstrup, D. M. (1986) · Cancer · doi:10.1002/1097-0142(19860515)57:10<2006::aid-cncr2820571022>3.0.co;2-6 · Cited by 1,581
Trojani, M., Contesso, G., Coindre, J. M., Rouesse, J., Bui, N. B., De Mascarel, A., Goussot, J. F., David, M., Bonichon, F., & Lagarde, C. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910330108 · Cited by 1,317
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
Evans, D. G. R., Baser, M. E., McGaughran, J., Sharif, S., Howard, E., & Moran, A. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.5.311 · Cited by 1,282
Neurofibromatosis. Conference statement, National Institute of Health development conference
Stumpf, D. A. (1988) · JAMA Neurology · Cited by 1,236
The neurofibromatosis type 1 gene encodes a protein related to GAP
Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90024-9 · Cited by 1,095 · cited 1×
“Neurofibromin, the NF1 gene product, acts as a tumour suppressor by promoting the inactivation of the proto-oncogene p21RAS and by controlling the mammalian target of rapamycin [2, 3].”
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.
Ferner, R. E., & Gutmann, D. H. (2002) · PubMed · Cited by 705
Self-citationVON RECKLINGHAUSEN NEUROFIBROMATOSIS: A CLINICAL AND POPULATION STUDY IN SOUTH-EAST WALES
HUSON, S. M., HARPER, P. S., & COMPSTON, D. A. S. (1988) · Brain · doi:10.1093/brain/111.6.1355 · Cited by 686
The NF1 tumor suppressor critically regulates TSC2 and mTOR
Johannessen, C. M., Reczek, E. E., James, M. F., Brems, H., Legius, E., & Cichowski, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503224102 · Cited by 601
Korf, B. R. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990326)89:1<31::aid-ajmg7>3.0.co;2-w · Cited by 390
An Introduction to Medical Statistics
GREENWOOD, M. (1932) · Nature · doi:10.1038/129188a0 · Cited by 388
The clinical and diagnostic implications mosaicism in the neurofibromatoses
Ruggieri, M., & Huson, S. M. (2001) · Neurology · doi:10.1212/wnl.56.11.1433 · Cited by 387
Elevated Risk for MPNST in NF1 Microdeletion Patients
De Raedt, T., Brems, H., Wolkenstein, P., Vidaud, D., Pilotti, S., Perrone, F., Mautner, V., Frahm, S., Sciot, R., & Legius, E. (2003) · The American Journal of Human Genetics · doi:10.1086/374821 · Cited by 310
A PET study of 18 FDG uptake in soft tissue masses
Lodge, M. A., Lucas, J. D., Marsden, P. K., Cronin, B. F., O'Doherty, M. J., & Smith, M. A. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050355 · Cited by 300
Self-citationFerner, R. E. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.3.353 · Cited by 217
Self-citation(2003) · PubMed · Cited by 190
Lucas, J. D., O’Doherty, M. J., Wong, J. C. H., Bingham, J. B., McKee, P. H., Fletcher, C. D. M., & Smith, M. A. (1998) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.80b3.0800441 · Cited by 173
Self-citationNational Institutes of Health Consensus Development Conference
(1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/67.3.741-e · Cited by 167
CT imaging in adults with neurofibromatosis‐1
Tonsgard, J. H., Kwak, S. M., Short, M. P., & Dachman, A. H. (1998) · Neurology · doi:10.1212/wnl.50.6.1755 · Cited by 158
Neurofibroma and Cellular Neurofibroma With Atypia
Lin, B. T.-Y., Weiss, L. M., & Medeiros, L. J. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199712000-00006 · Cited by 85
Neurofibromatous neuropathy in neurofibromatosis 1 (NF1)
Ferner, R. E., Hughes, R. A. C., Hall, S. M., Upadhyaya, M., & Johnson, M. R. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.021683 · Cited by 82
Self-citationUpadhyaya, M., Spurlock, G., Majounie, E., Griffiths, S., Forrester, N. A., Baser, M., Huson, S., Evans, D. G., & Ferner, R. E. (2006) · Human Mutation · doi:10.1002/humu.9429 · Cited by 51
Self-citation
Cited by
Neurofibromatosis Type 1 Revisited
Williams, V. C., Lucas, J., Babcock, M. A., Gutmann, D. H., Korf, B., & Maria, B. L. (2009) · Pediatrics · doi:10.1542/peds.2007-3204 · Cited by 695
Neurofibromatosis type 1: a multidisciplinary approach to care
Hirbe, A. C., & Gutmann, D. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70063-8 · Cited by 626
Clinical and genetic aspects of neurofibromatosis 1
Jett, K., & Friedman, J. M. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181bf15e3 · Cited by 501
UK guidelines for the management of soft tissue sarcomas
Dangoor, A., Seddon, B., Gerrand, C., Grimer, R., Whelan, J., & Judson, I. (2016) · Clinical Sarcoma Research · doi:10.1186/s13569-016-0060-4 · Cited by 477
Malignant Peripheral Nerve Sheath Tumors
Farid, M., Demicco, E. G., Garcia, R., Ahn, L., Merola, P. R., Cioffi, A., & Maki, R. G. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0328 · Cited by 354
Metadata
- Authors
- Ferner, R. E., Golding, J. F., Smith, M., Calonje, E., Jan, W., Sanjayanathan, V., & O’Doherty, M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 19
- Issue
- 2
- Pages
- 390-394
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2113286019
- Cited by
- 286
- References
- 22
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.